Cargando…
Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate.
Human head and neck tumours were successfully transplanted in athymic nude mice. In 14 xenograft lines the effect of 1 to 3 clinically active agents could be tested. Maximum tolerated doses were given daily for 3-7 days. Growth delay was estimated in terms of the number of volume doubling times gain...
Autores principales: | Braakhuis, B. J., Schoevers, E. J., Heinerman, E. C., Sneeuwloper, G., Snow, G. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011514/ https://www.ncbi.nlm.nih.gov/pubmed/6196043 |
Ejemplares similares
-
Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.
por: Boerrigter, G. H., et al.
Publicado: (1986) -
Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.
por: Thyss, A., et al.
Publicado: (1986) -
Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
por: Gerretsen, M., et al.
Publicado: (1992) -
Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells
por: Klaassen, I, et al.
Publicado: (2001) -
DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells
por: Martens-de Kemp, Sanne R., et al.
Publicado: (2013)